ангиотензин受体-neprilysin抑制剂与心力衰竭中改善的心脏自主功能有关
Andreas A Boehmer1, Tim Schubert1, Moritz Rothe1
1Division of Cardiology St. Josefs-Hospital Wiesbaden Wiesbaden Germany.
Journal of the American Heart Association
|July 31, 2024
概括
萨库比特里尔/瓦尔萨坦 (ARNI) 治疗显著改善了心脏自主功能,心力衰竭患者心脏衰竭和减少喷射分数. 这种增强的副交感音调可能与药物的体积卸载效应有关.
科学领域:
- 心脏病学 心脏病学
- 自主神经系统研究 自主神经系统研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 减少喷射分数 (HFrEF) 的心力衰竭与自主神经系统失衡有关.
- 已知萨库比特里尔/瓦尔沙坦 (ARNI) 能降低HFrEF患者的死亡率和住院病例.
- ARNI对心脏自主神经系统的影响仍未得到充分研究.
研究的目的:
- 研究ARNI治疗对HFrEF患者心脏自主神经系统的影响.
- 评估心率变化,心率,减速能力和再极化动态的变化.
- 为了将自主变化与心室功能和NT-proBNP水平相关联.
主要方法:
- 展望性,单中心队列研究,涉及63名HFrEF患者.
- 在ARNI启动前和3个月后进行标准化的12导荷尔特心电图,心声回声和实验室测试.
- 对心率变化 (SDNN,RMSSD),心率,减速能力和周期性再极化动态的分析.
主要成果:
- ARNI治疗显著增加了心率变化 (SDNN:25至36毫秒,P<0.001;RMSSD:12至19毫秒,P<0.001).
- 心率下降 (73±9至67±4bpm,P<0.001),减速能力有所改善 (2.1至4.4毫秒,P<0.001).
- 自主功能的改善与左心室射出分数 (29±6%至40±8%,P<0.001) 的增强和减少NT-proBNP (P<0.001) 相关联.
结论:
- 三个月的ARNI治疗显著增加了HFrEF患者的心脏副交感音调.
- 自主改进可以通过体积卸载来调解,从而为ARNI的好处做出贡献.
- 在HFrEF中,ARNI疗法积极调节心脏自主神经系统.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
578
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
578
01:22Heart Failure Drugs: β-Blockers
332
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
332
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
674
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
674
01:22Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
01:25Antihypertensive Drugs: Direct Renin Inhibitors
521
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
521